Efficacy and safety of olanzapine suppositories in terminally ill patients with delirium or nausea and vomiting.
Not Applicable
- Conditions
- delirium, nausea and vomiting
- Registration Number
- JPRN-UMIN000022172
- Lead Sponsor
- Shonan Central Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
We exclude children and patients with taking orally.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Responses to olanzapine therapy are evaluated based on clinical assessments by physicians. Information about the side effects is extracted from the electronic medical records of each patient.
- Secondary Outcome Measures
Name Time Method